EBENEZERBreaking
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Read full story on The New York Times →
Global — Gina Kolata and Rebecca Robbins
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
This report is published with credit to The New York Times. The wire sent a summary; open the original for any extra context. Read on The New York Times →
Source: The New York Times · Gina Kolata and Rebecca Robbins. Published 26 Aug 2026, 04:54 pm.
Most relevant
Her idea to create a “fantasy city” that celebrated her home region turned into a billion-dollar attraction that maintained its authentic feel.
Read on The New York Times →Editor’s choice
The social media giant settled with 47 states, the District of Columbia and U.S. territories, and agreed to make major changes to its products over claims its platforms endangered children.
Read on The New York Times →